NYSE:PENMedical Equipment
Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future
Penumbra (NYSE:PEN) has entered into a definitive agreement to be acquired by Boston Scientific.
The all cash transaction values Penumbra at approximately US$14.5b.
The deal is subject to approval by Penumbra shareholders and other customary closing conditions.
Penumbra focuses on medical devices for neurovascular and peripheral vascular conditions, areas that continue to attract attention as populations age and care standards evolve. Boston Scientific’s agreement to acquire NYSE:PEN adds...